Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 479

1.

R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.

Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Hsieh MH, Chen SA.

Can J Cardiol. 2014 Apr;30(4):405-12. doi: 10.1016/j.cjca.2014.01.005. Epub 2014 Jan 13.

PMID:
24582725
2.

Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.

3.

Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Huo Y, Piorkowski C, Bollmann A.

Circ Arrhythm Electrophysiol. 2014 Apr;7(2):281-7. doi: 10.1161/CIRCEP.113.001182. Epub 2014 Mar 8.

4.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.

5.

Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation--the potential role beyond the CHA₂DS₂-VASc score.

Chao TF, Tsao HM, Ambrose K, Lin YJ, Lin WS, Chang SL, Lo LW, Hu YF, Tuan TC, Suenari K, Li CH, Hartono B, Chang HY, Chung FP, Hanafy DA, Lin WY, Chen SA.

Heart Rhythm. 2012 Nov;9(11):1755-60. doi: 10.1016/j.hrthm.2012.06.039. Epub 2012 Jun 30.

PMID:
22760084
6.

Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.

Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY.

JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.

PMID:
26318604
7.

Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry.

Kornej J, Kosiuk J, Hindricks G, Arya A, Sommer P, Rolf S, Husser D, Lip GY, Bollmann A.

Clin Res Cardiol. 2015 Jul;104(7):603-10. doi: 10.1007/s00392-015-0823-6. Epub 2015 Feb 24.

PMID:
25707763
8.

Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.

Tanaka K, Yamada T, Torii T, Furuta K, Matsumoto S, Yoshimura T, Takase K, Wakata Y, Nakashima N, Kira J, Murai H.

J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1629-35. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.036. Epub 2015 Apr 20.

PMID:
25906940
9.

Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.

Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY.

Circ Arrhythm Electrophysiol. 2012 Apr;5(2):319-26. doi: 10.1161/CIRCEP.111.966713. Epub 2012 Feb 8.

10.

CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.

Chao TF, Lin YJ, Tsao HM, Tsai CF, Lin WS, Chang SL, Lo LW, Hu YF, Tuan TC, Suenari K, Li CH, Hartono B, Chang HY, Ambrose K, Wu TJ, Chen SA.

J Am Coll Cardiol. 2011 Nov 29;58(23):2380-5. doi: 10.1016/j.jacc.2011.08.045.

12.

CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.

Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.

Europace. 2014 Feb;16(2):202-7. doi: 10.1093/europace/eut210. Epub 2013 Jun 28.

PMID:
23813452
13.

CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.

Saliba W, Rennert G.

Am J Med. 2014 Jan;127(1):45-52. doi: 10.1016/j.amjmed.2013.10.004. Epub 2013 Oct 15.

PMID:
24384101
14.

Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation.

Abumuaileq RR, Abu-Assi E, López-López A, Raposeiras-Roubin S, Rodríguez-Mañero M, Martínez-Sande L, García-Seara J, Fernandez-López XA, Peña-Gil C, González-Juanatey JR.

BMC Cardiovasc Disord. 2015 Nov 19;15:156. doi: 10.1186/s12872-015-0149-3.

15.

Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation.

Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen TJ, Lip GY, Chen SA.

J Am Coll Cardiol. 2014 Oct 21;64(16):1658-65. doi: 10.1016/j.jacc.2014.06.1203.

16.

Which risk score best predicts perioperative outcomes in nonvalvular atrial fibrillation patients undergoing noncardiac surgery?

van Diepen S, Youngson E, Ezekowitz JA, McAlister FA.

Am Heart J. 2014 Jul;168(1):60-7.e5. doi: 10.1016/j.ahj.2014.03.015. Epub 2014 Apr 3.

PMID:
24952861
17.

CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation.

Parsons C, Patel SI, Cha S, Shen WK, Desai S, Chamberlain AM, Luis SA, Aguilar MI, Demaerschalk BM, Mookadam F, Shamoun F.

Mayo Clin Proc. 2017 Mar;92(3):360-369. doi: 10.1016/j.mayocp.2016.10.008.

PMID:
28259228
18.

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation.

Guo Y, Apostolakis S, Blann AD, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY.

Int J Cardiol. 2013 Sep 30;168(2):904-9. doi: 10.1016/j.ijcard.2012.10.052. Epub 2012 Nov 17.

PMID:
23167998
19.

Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?

Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen TJ, Lip GY, Chen SA.

J Am Coll Cardiol. 2015 Feb 24;65(7):635-42. doi: 10.1016/j.jacc.2014.11.046.

20.

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY.

Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. Epub 2013 Mar 21.

PMID:
23572113

Supplemental Content

Support Center